Juegang (Johnny) JU

Exec. Director / Sr. Dir., Head Of Clinical Dev. / Product Dev. Strategy at OnQualityrx

Juegang (Johnny) JU has a diverse work experience, beginning in 2008 as a Research Fellow at Shanghai Jiao Tong University's Lab of Synaptic Signaling and Behavioral Neurosciences. In 2009, they were a Campus Ambassador at Henkel. In 2010, they were a Senior CRA / CRA (Clinical Research Associate) at Pharmacons. From 2011 to 2012, they held a variety of roles at Novartis, Development, ICRO (International Clinical Research Operations), Quintiles, Clinical Operations, GFR (Global Functional Resourcing), and Amgen, GDO (Global Development Operations). From 2014 to 2016, they worked at Astellas as a CDAM/GSAM and as an Independent Consultant and Associate Director / Senior Manager, Clinical Strategy Planning at \u827e\u6606\u7eac. Since 2018, they have been working at OnQuality Pharmaceuticals Ltd. as an Executive / Senior Director, Clinical Development / Product Development Strategy and as a Director of Clinical Development.

Juegang (Johnny) JU has an education history spanning from 2004 to 2010. Juegang (Johnny) obtained a Bachelor of Science in Biotech & Genetic engineering from Shanghai Jiao Tong University between 2004 and 2008. Juegang (Johnny) then went on to pursue a Master of Science in Neuroscience (Bio-Medical Engineering) at the same university from 2008 to 2010. Juegang (Johnny) also holds three certifications from Barnett Educational Services, Cambridge Healthtech Institute and DrJ. The first two certifications are for the Barnett Accreditation – Expert GCP Exam for Managers and Staff interacting with investigational sites, obtained in 2011 and 2012 respectively. The third certification is a Certificate of CRA Training Course obtained from DrJ in 2010.

Links

Previous companies

Amgen logo
Novartis logo
Henkel logo
AstraZeneca logo

Timeline

  • Exec. Director / Sr. Dir., Head Of Clinical Dev. / Product Dev. Strategy

    October, 2019 - present

  • Director of Clinical Development

    September, 2018

View in org chart